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Acute graft-versus-host disease (GYHD) was induced in 
newborn Brown-Norway (BN) and DA rats by i. v. in-
jection of 3 X 107 Lewis (L) lymph node cells. Contro l 
B N and DA rats received syngeneic cells. R ats were in-
jected i. v. with [methyl-3H]th ymidine for] h before being 
killed at 1, 2, 4, 5, 6, 8, 10, 11 , 12, 13, and 14 days after 
the cellular inoculum. A piece of ventral abdo minal skin 
was removed . Autoradiography was used to determine cel l 
proliferative activity (labeling index, Ll) in mas t cell s and 
fi broblas ts of the dermis and basal cells of the epidermis. 
In addition, the number of mast cells per high-power fi eld 
was determined for all 4 groups ofrats: control DA, GVHD-
DA, control BN , and GVHD-BN . O nly GVHD-BN rats 
demonstrated ex tensive dermatitis. T he LI of mast cells, 
fibrob lasts, and basal cell s decreased in control rats w ith 
increasing age. Although there were differences between 
DA and BN rats, there was a genera l pattern of increased 
proliferation of mast cel ls at ea rly time points of GYHD 
G raft-versus_host disease (G VHD) is a patho logic pro-cess wh ich results fro m the challenge o f an immu-no incompetcnt host w ith allogeneic immunocom-petent donor lymphoid cells. General systemic effects of this process include weight loss, stunted growth , 
and diarrh ea, w ith specific effe cts on vario us organs prod ucing 
lymphadenopath y, spleno megaly, and hepa to mega ly [1]. Lesions 
in both the gas trointestinal trac t [2] and skin 13] have also been 
documented. 
Induction o f dermatitis in GV H D has been reported in rats 
[1,4] and hamsters [3] receiving foreig n lymphocytes, and both 
primates [5] and humans [6,7] receiving allogeni c bone marrow 
transplants foll owing host irradiation. The histologic changes found 
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fo llowed by a decrease to or below control levels. The 
number of mas t cell s per high-power field also in creased 
at ea rl y time intervals in both the DA and BN GYHD rats, 
but decreased significantly at later time points. T hese data 
confirm previous studies on chroni c GYHD which dem-
onstrated a decrease in the number of mas t cell s in the skin . 
Fibroblast LI was decreased at day 1 in both DA and B N 
GYHD rats. In GYHD-DA, fib roblast Ll remained de-
pressed w hile GVHD-B N dem onstrated a second peak in 
LI at day 10 befo re decl ining below contro l levels. The 
most prominent basal cell response occurred in GYHD-
BN between days 6-14 and is probably indica tive of an 
attempted reparative response associated w ith GY HD der-
matiti s in this species . These data demonstrate that the 
activation o f m as t cell s (proli feration and subsequent de-
granulation) correlates temporally with cell kinetic altera-
tions occurring in the dermis and epidermis during acute 
GYHD. ) !rilles! Dennaro/ 88:369-374, 1987 
in all of these m odels is generall y considered to be characteristi c 
of GVHD . In additio n to the g rossly vi sible erythematous der-
matiti s w ith hair loss and bullae formation [8], mi crosco pic find-
ings include epithelial cel l necrosis w ith hyperkeratosis and dys-
keratos is, accompanied by lymphocy tic and mo no nuclea r 
infiltration of th e epidermis [3J. Necrotic epitheli al cell s arc typ-
ica ll y present within suprabasa l lacun ae and acco mpan ied by sat-
ellite lymphocytes, a characteri stic findi ng in GV HD [7]. In acute 
GVHD, changes w ithin the der mis include ede ma, alteratio n of 
the co llageno us reticulum , and lymphocytic infiltrat io n as wel l 
as an increase in the number of mast ce lls [3,6]. The purpose of 
the present stud y was to quanti fy tempo ra l changes in cellul ar 
pro liferation within the dermis and epidermis during acute GV H D 
including the basa l cells of the epidermis, fibrob las ts, and mast 
cells in the dermis. 
MATERIALS AN D METH ODS 
Animals Rats of bo th sexes of do m es ticall y maintained Lewis 
(L, RTl i) , Brown N o rw ay (B N , RT1") and DA (DA, RT1 ') 
strains were emplo yed in these studies . N ewborn BN and DA 
rats servcd as ex perimental and control animals. T hree to six 
litterm ates were killed at each time po ine. Litter size varied frolll 
6-10 pups in number. T he BN strain demo nstrated improved 
survival as compared to the DA rats undergoing GV HD . H ow-
ever, th e DA-GVHD rats demonstrated no g ross ly visible der-
matitis in comparison to the dermatitis w ith hair loss exhibited 
by th e B N -GVHD rats . 
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Cell Suspensions and Injections Cervi cal, axill ary , and bra-
chial lymph nodes were obtained from male L, DA, o r BN rats, 
weighin g 150-250 g. Cell suspensions were prepared as described 
previously [9]. Viability w as 90- 95% as assessed by the trypan 
blue exclusion technique. Thirty million L (experimental), BN 
(control), o r DA (control) lymph node cells in a vo lume of 0.1 
ml were ir~j ec ted i. v . into newborn BN or DA rats via the orbital 
branch of the anterior facial vein [1, 9] within 24 h after birth . 
In this stud y th ere were 4 g roups of rats: control DA (receiving 
DA cells), G VHD DA (receiving L cells), control BN (receiving 
BN cell s), and GVHD BN (receiving L cells). The rats received 
no conditionin g irradiation or chemotherapy prio r to cell inj ec-
tion . 
[3H]Thymidine Labeling Procedures O n days 1, 2, 4, 5, 6, 
8, 10, 11 , 12, 13, and 14 after inj ection of the cellul ar inoculum , 
1 JLC i/g body weight, [3H]th ymidine (sp ac t = 6.7 C i/ mmol, 
New England Nuclear Co., Boston, Massachusetts) was admin-
istered i. v. into experimental and control rats. Rats 4 days of age 
and under were inj ected by th e anteri or fac ial vein ; those older 
th an 4 days received i. v. injections by way of the fem oral vein 
[9, 10]. Ra ts were killed 1 h after injection and a piece of ventral 
abdominal skin, approximately 1 cm square, was removed and 
fixed in Davidson's solution. In the case of th e BN-G VHD rats, 
abdomin al skin biopsies were removed from areas of observed 
derm atitis w here th ey occurred . 
Autoradiographic Procedures T iss ues were fi xed fo r 24 h 
and th en embedded in g lycol meth acrylate. Subsequentl y, 1-JLm 
sections w ere cut on a So rvall JB-4 microtome and m ounted on 
acid-clea ned, gelatin-chrom alum-subbed slides. The slides with 
attached sections w ere dipped in N T B-3 Nuclear Track Emulsion 
(Eastman Kodak, Rochester, N ew York) and exposed in black 
slide boxes at 4°C fo r 10 days. T he exposure period was deter-
mined fro m bo th ho t and cold tes t slides. Slides w ere developed 
in D-1 9 developer , w ashed briefl y in distilled wa ter, fIxed in 
Kodak fi xer, and subsequently stained with 1 % buffered toluidine 
blue. 
Counting of Autoradiographic and Data Analysis The 
[3H]th ymidine labeling index (U), labeled cell s/1000 cells, w as 
determ ined fo r several cell types in the epidermi s and dermis. 
T he LI was determined for total basal cells between the peg re-
gions, basa l cells in the (rete) peg regions, fi broblas ts, and m as t 
cells in the dermis. In addition , m as t cells w ere counted per 10 
high-power (1000 x) oi l immersion fi elds. Cell counts were per-
fo rm ed on skin from 3 rats per time interval with at least 15 
secti ons evaluated at each time interval. At least 1000 cells were 
counted fo r basa l cells, basal (peg) cells, and fibrobl as ts. All m as t 
cell s observed w ere co unted . Three g rains was the criterion for 
a labeled cell and background w as < 1 grain/1 00JL2 fi eld area. The 
LI fo r control and experim ental rats were compared (control DA 
vs GVH D D A and control BN vs GVHD BN) usin g an unpaired 
Student's I-tes t (p :=; 0.05) . 
RESULT S 
The results o f [3Hlthymidine LI analysis o f the basal cells are 
shown in Fig 1. Control DA, contro l B N , and GVHD B N groups 
all demonstra ted a steady decrease in LI between day 1 and days 
10-14. T his pattern is indica tive o f a decreased LI followin g birth . 
In bo th GVH D groups there was a lower LI at several ea rl y time 
intervals compared to controls. In the GVHD BN group LI in-
creased signifi ca ntl y over control s from days 6-14. 
T he LI data for basa l cells in epidermal rete pegs arc shown in 
Fig 2. T he pattern was similar to th at demonstrated in the basa l 
cells although the G VHD DA rats demonstrated a lower LI th an 
controls between days 5-10. An exa mple of labeling in epiderm al 
basal cells and an underlying fibroblas t o f a day-4 GVHD DA 
rat is shown in Fig 3. As mentioned previously the BN-G VHD 
rats demonstra ted extensive derm atitis w ith associated hair loss. 
Histologicall y, the skin of these rats exhibited derm al infiltration, 
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Figure 1. Basal cell label ing index of GVHD-DA and GV HD-BN neo-
natal rats compa red to cont rols. *p < 0.05 co mpared with syngeneic 
contro l group . **p < 0.01 compared with syngeneic control group . 
with edem a, erythema , and necrosis of hair follicl es . Epidermal 
infi ltration also occurred w ith increase in thi ckness and hyper-
troph y of the malpighian layer as well as some necrosis (Figs 4, 
5) . These patho logic changes were most d ra mati c between 8-1 4 
days in the BN rats. T he D A rats with G VHD died by day 10 
and although they ex hibited mild derm al and epidermal infiltra-
tion, there was little evidence of an in creas~ in thi ckness of the 
malpighian layer on day 8, as well as no gross dermatitis. 
The LI data for derm al fib roblas ts are shown in Fig 6. As in 
the epidermis, fibroblast LI fo r the 2 contro l groups decreases 
steadily th roughout the period analyzed. In the case of the GVH D-
D A rats there is an ea rly peak in LI foll owed by a sharp, statis-
tica ll y signifi cant decline. In the BN G VHD group there is de-
creased Ll until day 6, fo llowed by a gradual increase which 
peaked at day 10, and a sharp decline at later tim e intervals. This 
increase on days 8-10 correlated w ith an infiltration of lymphoid 
cells. 
Mast cell Ll in both control groups decreased throughout the 
experim ental peri od (Fig 7) . In the GVHD-DA group th ere was 
a dramatic peak at day 2 fo llowed by a decline to con trol levels. 
In the GVHD-BN group mas t cell LI was significa ntl y lower than 
controls at day 1, pea ked on day 2 with a plateau from days 2-8, 
foll owed by a decline o f LI to below control levels (day 11 ). An 
example of a [3H]thymidine-labeled mast cell from a day 2 GVHD-
DA rat is shown in Fig 8. 
T he number o f mas t cells per 10 high- power fie lds is shown 
in Fig 9. T he control groups show a relativel y stable number of 
mas t cells in the dermis o f the skin with an increase in the control 
BN group (days 11-15). In the G VHD-DA group there arc fewer 
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Figure 2. Basal cell peg labeling index of GVHD-DA and GVHD-BN 
neonatal rats compared with controls. *, **, see Fig 1 legend. 
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Figure 3, L~bdin g in epidcrlllal b3s31 cdls and an undcrl yin g fib ro blast 
ofG VHD-DA r3t on d3 y 4. 
mas t cell s at the initi ation o f the ex perimCl1t w ith a pea k at da y 
2 and a signifi cant deCl'ease on da ys 5, 8, and 10. The number o f 
mas t cells in the G VI-ID-BN g roup was signifi ca nt ly hi gher than 
contro ls on da y G, but declin ed signifi cantl y on days 10- 15. An 
a rea of dermis fro m a G VI-I D rat illustratin g th e pn:scn ce of 
n um ero us ma st ce ll s is sho wn in Fig 10. 
DI SC U SS IO N 
T he results o f the present stud y demo nstrate sequenti al changes 
in pro li feration of inter-peg basal ce lls, basa l cells o f th e rete pegs , 
m as t ce lls, and fibro blasts w ithin th e skin of neonatal DA and 
B N rats undergo in g acute G VI-ID. T here were signi fica nt st rain 
d ifferences in th e cellular response of the skin dmin g the course 
of the d isease process reRectin g the gross differences in appea ran ce 
o f the skin in DA and BN rats fo ll owin g indu ction of G VI-ID . 
Neonatal G VI-ID in th e DA strain ca used a decrease in th e number 
of pro liferatin g basal cell s and fibro blasts after days 2-4, w hi ch 
persisted unti l day 10 wh en mos t anim als were dead . In contras t , 
Figure 4. Arc~ o f epidermis between the pegs fro lll a day 12 contro ll3N 
neonatal rat. N o ti ce that the s tr~ tlll11 111~lpighii is 2-3 cells thi ck. 
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Figure 5. Are:l o f cpickrll1i s bctwecn the pcgs fro ll1 a d~y 12 GV H D-
l3N Il con3t31 rar. N o ti ce that thc st r3l111l1 '113 lp igh ii is sO l11 cwhat hyper-
trop hic and is 4-5 cdls in thi ckness. Noti ce also some necro ti c cell s . 
L1 clunges in 11<:onatal B N G VI-I D rats dem onstrated a day 2-10 
in crease in basal ce ll and fi b ro blast pro li fe rat ion ovel' contro ls. 
T he hi sto logic changes demonstrated in prev ious stu d ies usin g 
a hamster F, - hybrid m odel 13], a neonata l rat G VI-I D mode l II], 
an d hum an G VI-I D after bone marrow transp lantat ion IG,71 in-
clude eryth ema, ede ma, presence o f brge numbers of m ast cells, 
infiltrati on o f the dermis by mononuclea r cell s w ith vacuo liza tio n 
of epiderma l cd ls, hyperkeratini za tio n o f th e epidermis, and al-
terati on of the o rientatio n of co lla genous fi bers in the dermis. 
M any o f th ese changes were o bserved in the G VI-I D-B N rats in 
th e present stud y w here der mal and epide rl11 al in fi ltratio n of 
mono nuclea r cell s and so me fo lli CLlbr and epiderm al necrosis oc-
curred between days 8-14. Therefo re, the cel lul ar patho logic 
changes in th e sk in of G VI-ID-BN rats appear to co rrelate w ith 
th e o bserved changes in LI (decline, pea k, fo llowed by a decl in e). 
This pat te l'l1 is sil11ilar to that seen in o ther o rgans of ad ul t rats 
during G VI-I D, altho ugh the t imin g of cellu la r in fi ltration and 
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Figure 6. Fibro bbst labeling index ofGV H D- DA and GV H D-BN neo-
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stimulated cell pro liferation is different. For exa mp le, using the 
adult FI-hybrid model for acute G VHD, proliferation of infi l-
trat ing cell s has been demonstrated ve ry ea rl y in G VHD (days 
1-4) in both th e periportal infiltrating cells of the liver [11] and 
ill the periductal infiltrating cells in the subm andibul ar g land [1 21. 
Whi le so me infiltrat ing cells were demonstrated in the skin at 
later tim e points in the present stud y, extensive cell pro li fe ration 
of infiltrating ce lls was not o bserved . 
T he present results also differ somewhat from studies of human 
G VHD w hi ch indica te an ea rl y ep iderm al cell lesion w ithin the 
basal cells of the rete pegs during acute G VHD [131. The pattern 
of cell proli ferat ion in the present study w ithin rete pegs was 
so mew hat similar to th at of the suprapapillary regions of the basa l 
layer between days 1-10. However, after day 10 in th e BN GVHD 
model , proli ferat ion decreased almost fourfo ld in the peg area but 
continued to be sig ni fi ca ntly elevated until day 14 in the inter-
peg area (Figs 1, 2). N everthel ess, even th o ugh pro liferatio n 
marked ly decreased in th e rete it must be noted th at ex tensive 
rete dama ge was not found in either of the GV HD models in-
cluded in the present study. Such less se vere rete pathology in 
neonata l rat vs human G VHD may be due to the differences in 
th e characteris tics ofGVHD in th ese species , the acute 10-14 days 
time course used in the present study , as well as differences in 
ho min g ability between human bo ne marrow vs rat lymph node 
and spleen cells to the skin . 
T he results o f the present study also demonstrate that th ere is 
a signifi cant tempora l change in bo th th e proli feration and den sity 
of dermal mast cells in acute GV HD . Initi al in crease in the number 
of proliferatin g mast cells in both strains was fo llowed by a de-
Figure 8. ,.11-I]T hy mid inc labeled m ast ce ll s fro m a day-2 G VHD-DA 
rat. 
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crease in both mas t cell number and pro li feratio n to levels below 
those o f controls. Both of these events chronologicall y precede 
the in crease in fibrob last proliferatio n whi ch also occurred in both 
strains. T hus, the proliferation of mast cells and the possible 
mitogenic effects induced by their activa tion and degranulation 
may be of considerable relevan ce to the progression of acute 
GVHD . 
T he turnover and proli fe ration of mast cells under normal and 
patho logic conditions has been studied by a number of investi-
ga to rs; howeve r, the results rem ain eq uivoca l. T he prevalent view 
has been that mast cells differenti ate fro m a bone marro w-deri ved 
precurso r r14J and are ca pable of limited o r no mito tic ac tivity 
in ad ult rodents [1 5-17J. In contrad iction to this view, 
rJI-I]th ymidine incorporation has been o bserved in rat embryos 
at va ri ous stages P 81 and mitoses and [3HJthymidine incorpo-
ratio n have been o bserved in peritoneal mas t cell s fro m rats aged 
0.5-120 days [1 9,20J. In add itio n, evidence from adult rodents 
sugges ts that bo th peritonea l mast cell s and co nn ective tissue mast 
cells of the skin and ton gue arise fro m proliferation of m ature 
mas t cells 114,21 J. Mi to ticall y active mast cells have also been 
demonst rated in the rat mesentery and subcutaneous connective 
tiss ue fo ll owing i. p. injectio ns of the mas t cell-degranu lating (his-
tamine-releasing) polyamine, compound 48/80 r22]. Recent work 
by Kitamura and colleagues [231 indi ca tes that under normal con-
ditions mast cells are derived from hematopoietic stem cells. M ast 
cell precursors leave the bone marrow and travel to the connective 
tissues. T hese precursors proliferate and subsequently differen-
ti ate into mas t cell s, although some mast cells may reta in their 
proliferative ca pacity and funct ion as loca li zed precursors. T he 
Figure 10. Area of dermis illustrating numerous mas t cell s. 
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present study confirms th at [3H]thymidine incorporation and pre-
sumably cell proliferation ca n occur in dermal mast cells of the 
neonatal rat undergoi ng an acute GVHD reaction. The question 
remains whether these proliferating mast cells are derived from: 
(1) new agranular mas t cell precursors from the bone marrow, 
(2) mature mast cells which differentiate, proliferate, and sub-
seguently redifferentiate into g ranular mast cells, andlor (3) pro-
liferation of mature mast cells. 
The temporal seq uence of increased [3H]thymidine incorpo-
ration, increased numbers of mast cells , subsequent decreased 
numbers of mast cells followed by stimulation of fibrobl as tic and 
epidermal cell proliferation may indicate a link between mas t cell 
activation and mitogenesis of dermal and epidermal cell popu-
lations. Studies of in vivo and organ-cultured mesentery dem-
onstrate that histamine fro m mast cells provides a loca lized mi-
togenic stimulus in neig hbo rin g no rmal connective tissue cells of 
the rat [24] . Administration of compound 48/80 stimulates 
[3H]thymidine incorporation into both mesothelial-like and fi-
broblast-like cells in the rat mesentery [25], derm al cells , and 
epi thelial stru ctures in the skin [26] . 
In addition, other interactions between mas t cells and fibro-
blasts have been previously reported, including phagocytosis by 
fibroblasts of granules released by mast cells in vitro followed by 
increased secretion from those fibrobl asts [27]. Also, in vivo stud-
ies have suggested a similar response in the dermis following 
ad ministration of various agents [28]. Therefore, activation of 
mast cells in diseases such as GVHD [29,30] and scleroderma [31] 
may play a role in th e fibrotic changes associated with those 
diseases. However, the specific ability of mast cells and their 
secretory products to stimulate fibrobl as tic and epidermal cell 
proliferation requires further studies. 
The quantitative reduction in mas t cells (later stages) following 
an initial increase in their number may be due to several possible 
mechanisms: death of the cells, emigration from the skin, or 
degranulation [29]. To date, no cell surface markers specific for 
mast cells have been identified . The toluidine blue sta in used to 
identify m as t cells in this study has been shown to stain only m as t 
cell granules. Therefore, in the present study only g ranulated mast 
cells were detected in the dermis. Sequential electron micro-
graphic studies of mas t cell g ranules during GVHD may help 
cla rify whether mast cell degra nulation occurs in GVHD. 
As mentioned previously , infiltrating cells have been implica ted 
in the pathogenesis of GVHD in human skin, rat submandibular 
gland [12] and liver [11], as well as small intes tine [2] . [n these 
sys tems it is believed that cellular infiltrates composed primarily 
of donor T cells release lymphokines (gamma-interferon andlor 
interleukin 2) which are res ponsible for proliferation, dam age, 
and consequent attempts at repair. In the gas trointes tinal mucosa, 
the characteristics of these cell-mediated, delayed-type hypersen-
sitivity reactions include: villus atrophy, lengthening of the crypts , 
increased mitotic activity [2], and express ion of class II major 
his tocompatibility complex ([a) anti gens on cry pt cells [32]. Stud-
ies in adult mice [4,33] and rats also have demonstrated expression 
oEra antigen on epidermal keratinocytes durin g advan ced GVHD. 
T he possible relationship of the presently reported basal cell hy-
perplasia and hyperkeratiniza tion to such previo usly repo rted 
expressio n of la antigen remains to be elucidated. 
The fact th at there is a significant amount of proliferation in 
the present studies without coincident infiltration implies that 
dermal and epidermal cells are reacting to systemically secreted 
fac tors. Earlier studies have shown th at activated T cells can affect, 
by secretion of lymphokines, various events such as histamine 
production [34] and mast cell growth [35]. Although there is no 
direct evidence for this process in the present study, a histamine-
releasing substance has been identified from stimulated human 
mononuclear cells which causes degranulation of basophils and 
release of histamine from the granules [36] . [t is possible that 
similar mechanisms may be involved during the acute GVHD 
reaction in the skin. 
It is not completely clear as to why there are differences between 
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the BN and DA rats in terms of their general susceptibility to 
GVHD and manifestation of dermatitis durin g the disease process. 
The data in Figs 1, 2, 6, 7, and 9 indica te that either a higher 
initial level of proliferatin g basal cells, fibrobl asts , and mas t cells 
occurs in DA rats andlor the susceptibility to pro liferative stimuli 
is higher in the DA vs BN newbo rn rat after induction ofGVHD. 
Since DA rats are approximately 0.5-1 g sm aller than BN rats 
at birth (Clancy, unpublished observations) it is possible that the 
disease process is simply accelerated in DA vs BN rats because 
they received more L cells per gram body weight than the BN 
rats. Such an accelera ted G VHD in the DA rats may result in 
mortality before the possible m anifestatio n of dermatitis. 
[n summary, the present study documents changes in cell pro-
liferation in basal cells, basal cells of the rete pegs, and dermal 
fibroblas ts of the skin during acute lethal GVHD in 2 strains of 
neonatal rats. In addition , alterations in the number and cell pro-
liferative activity of mast cells were observed. These data suggest 
a temporal relationship between mas t cell activatio n and degran-
ul ation and o ther events during GVHD. However, the patho-
biology of the GVHD system further co mplica tes the poorly 
understood interaction of T cells, mas t cells, fibrobl as ts, basal 
cells, and other cells present in the skin under normal conditions . 
Til e al/th ors tllallk JI/dy Maples for her carejili typillg of til e lIIalll ISCript. 
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